Mogroside V can effectively regulate the insulin resistance of HepG2 cells and improve the blood glucose levels, insulin sensitivity, glucose and lipid metabolism disorders, and oxidative stress in T2DM rats. The gene discussed is INS; the disease is type 2 diabetes mellitus.